Related Experiment Videos
Nuclear factor kappa B signaling in macrophage function and atherogenesis
Sofia Xanthoulea1, Danielle M J Curfs, Marten H Hofker
1Department of Molecular Genetics, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands.
Current Opinion in Lipidology
|September 9, 2005
Summary
Nuclear factor kappaB (NF-κB) plays a complex role in atherosclerosis, influencing inflammation, cell survival, and resolution. Targeted modulation of NF-κB activity may offer safer therapeutic strategies for this chronic inflammatory disease.
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Atherosclerosis is a chronic inflammatory disease affecting medium and large arteries.
- Nuclear factor kappaB (NF-κB) transcription factors are key regulators of inflammatory responses.
- Aberrant NF-κB regulation is implicated in numerous diseases.
Purpose of the Study:
- To review recent literature on the role of NF-κB in atherosclerosis, focusing on macrophages.
- To discuss signaling pathways that regulate NF-κB activity in the context of this disease.
Main Methods:
- Literature review of recent studies on NF-κB in atherosclerosis.
- Focus on macrophage involvement and regulatory signaling pathways.
Main Results:
- Activated NF-κB is present in human atherosclerotic lesions.
- NF-κB signaling pathways are critical at all stages of atherogenesis.
- NF-κB's role is complex, with both pro-inflammatory and anti-inflammatory effects, influencing cell survival and proliferation.
Conclusions:
- NF-κB is a target for drug interventions due to its role in various diseases.
- Cell type-specific or disease stage-specific modulation of NF-κB activity is needed for safer therapeutic solutions.